As of January 22, 2025, Revolution Medicines (RVMD) has a market cap of $7.60 billion USD. According to our data, Revolution Medicines is ranked No.2050 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $7.60 B |
-6.02%
|
Dec 31, 2024 | $8.08 B |
52.51%
|
Dec 29, 2023 | $5.30 B |
20.40%
|
Dec 30, 2022 | $4.40 B |
-5.36%
|
Dec 31, 2021 | $4.65 B |
-36.42%
|
Dec 31, 2020 | $7.32 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
Moderna
MRNA
|
$14.88 B |
0.000 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Market Cap | = | RVMD Stock Price | * | RVMD Shares Outstanding |
= | $41.10 | * | 0.18 B | |
= | $7.60 B |